Cardiac Fibrosis and Heart Failure: Cause or Effect? (Advances in Biochemistry in Health and Disease)

Published by Springer, 2015
ISBN 10: 3319174363 / ISBN 13: 9783319174365
Used / Hardcover / Quantity Available: 0
From Books Express (Kittery, ME, U.S.A.)
Available From More Booksellers
View all  copies of this book

About the Book

We're sorry; this specific copy is no longer available. AbeBooks has millions of books. We've listed similar copies below.

Description:

Ships with Tracking Number! INTERNATIONAL WORLDWIDE Shipping available. May not contain Access Codes or Supplements. May be ex-library. Shipping & Handling by region. Buy with confidence, excellent customer service!. Bookseller Inventory # 3319174363

About this title:

Synopsis:

The unique biology of cardiac fibroblasts and related cells, such as cardiac myofibroblasts and valvular interstitial cells, distinguish them from other fibroblastic cells, a concept that is only beginning to be widely appreciated. Further, the natural signals that stimulate and inhibit cardiac fibrosis within these cells are not well understood. This volume compiles articles that address the molecular mechanisms that control the synthesis and secretion of the cardiac ECM. The book showcases chapters that highlight discussion of role of Transforming Growth Factor β (TGFβ), an important fibrogenic cytokine and its downstream effectors SMAD in many cardiac diseases. Further, the contributions highlight information to discuss endogenous inhibitors of cardiac fibrosis, as well as advances in tissue engineering specific to matrix in the heart. Finally, discussions of unifying mechanisms of matrix remodeling in valves and myocardium are presented.

The mechanisms involved in the stimulation of cardiac fibrosis are not fully understood. In most cases the marginal attenuation of cardiac fibrosis as a result of a given therapy is a beneficial side-effect linked to other primary effects on other cells, especially cardiomyocytes. Very few drugs or agents are known to affect the function and dysfunction of cardiac fibroblasts and myofibroblasts alone. The book helps to translate the information gathered within to allow us to alter the course of fibrogenic events that are typical of cardiac fibrosis, and thereby reduce their burden on the patient and on society itself.

About the Author:

Dr. Jeffrey Wigle is an Associate Professor at the University of Manitoba, Winnipeg, Canada. His research focuses on the transcriptional pathways involved in regulating the growth and development of the cardiovascular system. He has characterized a number of transcription factors that are critical for the development of the lymphatic vasculature and the phenoconversion of fibroblasts to myofibroblasts. He is currently studying the transcriptional feedback loops that determine the fibroblastic phenotype.

Dr. Ian M.C. Dixon is a Professor of Physiology and Pathophysiology at the University of Manitoba, Winnipeg, Canada.  His research addresses heart failure following myocardial infarction and the contributing role of dysfunctional extracellular matrix in these hearts. He is also interested in mechanisms of fibroblast phenotype regulation, cardiac fibroblast SMAD protein signaling as well as other signaling proteins that may oppose the fibrogenic influence of TGF-b1 in health and disease. He has been engaged over the past 24 years in multidisciplinary research in cardiovascular matrix biology. 

"About this title" may belong to another edition of this title.

Bibliographic Details

Title: Cardiac Fibrosis and Heart Failure: Cause or...
Publisher: Springer
Publication Date: 2015
Binding: Hardcover
Book Condition: Good
Edition: 2015.

Top Search Results from the AbeBooks Marketplace

1.

Ian M.C. Dixon
Published by Springer (2015)
ISBN 10: 3319174363 ISBN 13: 9783319174365
New Quantity Available: 5
Seller:
Books2Anywhere
(Fairford, GLOS, United Kingdom)

Book Description Springer, 2015. HRD. Condition: New. New Book. Shipped from UK. Established seller since 2000. Seller Inventory # S0-9783319174365

More information about this seller | Contact this seller

Buy New
US$ 184.47
Convert currency

Add to Basket

Shipping: US$ 6.50
From United Kingdom to U.S.A.
Destination, rates & speeds

2.

Ian M.C. Dixon, Jeffrey Wigle
Published by Springer 2015-07-09 (2015)
ISBN 10: 3319174363 ISBN 13: 9783319174365
New Hardcover Quantity Available: 2
Seller:
Chiron Media
(Wallingford, United Kingdom)

Book Description Springer 2015-07-09, 2015. Hardcover. Condition: New. Seller Inventory # 6666-LBR-9783319174365

More information about this seller | Contact this seller

Buy New
US$ 182.08
Convert currency

Add to Basket

Shipping: US$ 12.12
From United Kingdom to U.S.A.
Destination, rates & speeds

3.

Ian M. C. Dixon
Published by Springer-Verlag Gmbh Jul 2015 (2015)
ISBN 10: 3319174363 ISBN 13: 9783319174365
New Quantity Available: 1
Seller:
Rheinberg-Buch
(Bergisch Gladbach, Germany)

Book Description Springer-Verlag Gmbh Jul 2015, 2015. Buch. Condition: Neu. Neuware - The unique biology of cardiac fibroblasts and related cells, such as cardiac myofibroblasts and valvular interstitial cells, distinguish them from other fibroblastic cells, a concept that is only beginning to be widely appreciated. Further, the natural signals that stimulate and inhibit cardiac fibrosis within these cells are not well understood. This volume compiles articles that address the molecular mechanisms that control the synthesis and secretion of the cardiac ECM. The book showcases chapters that highlight discussion of role of Transforming Growth Factor beta (TGFbeta), an important fibrogenic cytokine and its downstream effectors SMAD in many cardiac diseases. Further, the contributions highlight information to discuss endogenous inhibitors of cardiac fibrosis, as well as advances in tissue engineering specific to matrix in the heart. Finally, discussions of unifying mechanisms of matrix remodeling in valves and myocardium are presented. The mechanisms involved in the stimulation of cardiac fibrosis are not fully understood. In most cases the marginal attenuation of cardiac fibrosis as a result of a given therapy is a beneficial side-effect linked to other primary effects on other cells, especially cardiomyocytes. Very few drugs or agents are known to affect the function and dysfunction of cardiac fibroblasts and myofibroblasts alone. The book helps to translate the information gathered within to allow us to alter the course of fibrogenic events that are typical of cardiac fibrosis, and thereby reduce their burden on the patient and on society itself. 436 pp. Englisch. Seller Inventory # 9783319174365

More information about this seller | Contact this seller

Buy New
US$ 191.83
Convert currency

Add to Basket

Shipping: US$ 18.64
From Germany to U.S.A.
Destination, rates & speeds

4.

Ian M. C. Dixon
Published by Springer-Verlag Gmbh Jul 2015 (2015)
ISBN 10: 3319174363 ISBN 13: 9783319174365
New Quantity Available: 1
Seller:
BuchWeltWeit Inh. Ludwig Meier e.K.
(Bergisch Gladbach, Germany)

Book Description Springer-Verlag Gmbh Jul 2015, 2015. Buch. Condition: Neu. Neuware - The unique biology of cardiac fibroblasts and related cells, such as cardiac myofibroblasts and valvular interstitial cells, distinguish them from other fibroblastic cells, a concept that is only beginning to be widely appreciated. Further, the natural signals that stimulate and inhibit cardiac fibrosis within these cells are not well understood. This volume compiles articles that address the molecular mechanisms that control the synthesis and secretion of the cardiac ECM. The book showcases chapters that highlight discussion of role of Transforming Growth Factor beta (TGFbeta), an important fibrogenic cytokine and its downstream effectors SMAD in many cardiac diseases. Further, the contributions highlight information to discuss endogenous inhibitors of cardiac fibrosis, as well as advances in tissue engineering specific to matrix in the heart. Finally, discussions of unifying mechanisms of matrix remodeling in valves and myocardium are presented. The mechanisms involved in the stimulation of cardiac fibrosis are not fully understood. In most cases the marginal attenuation of cardiac fibrosis as a result of a given therapy is a beneficial side-effect linked to other primary effects on other cells, especially cardiomyocytes. Very few drugs or agents are known to affect the function and dysfunction of cardiac fibroblasts and myofibroblasts alone. The book helps to translate the information gathered within to allow us to alter the course of fibrogenic events that are typical of cardiac fibrosis, and thereby reduce their burden on the patient and on society itself. 436 pp. Englisch. Seller Inventory # 9783319174365

More information about this seller | Contact this seller

Buy New
US$ 191.83
Convert currency

Add to Basket

Shipping: US$ 18.64
From Germany to U.S.A.
Destination, rates & speeds

5.

Ian M. C. Dixon
Published by Springer-Verlag Gmbh Jul 2015 (2015)
ISBN 10: 3319174363 ISBN 13: 9783319174365
New Quantity Available: 1
Seller:
AHA-BUCH GmbH
(Einbeck, Germany)

Book Description Springer-Verlag Gmbh Jul 2015, 2015. Buch. Condition: Neu. Neuware - The unique biology of cardiac fibroblasts and related cells, such as cardiac myofibroblasts and valvular interstitial cells, distinguish them from other fibroblastic cells, a concept that is only beginning to be widely appreciated. Further, the natural signals that stimulate and inhibit cardiac fibrosis within these cells are not well understood. This volume compiles articles that address the molecular mechanisms that control the synthesis and secretion of the cardiac ECM. The book showcases chapters that highlight discussion of role of Transforming Growth Factor beta (TGFbeta), an important fibrogenic cytokine and its downstream effectors SMAD in many cardiac diseases. Further, the contributions highlight information to discuss endogenous inhibitors of cardiac fibrosis, as well as advances in tissue engineering specific to matrix in the heart. Finally, discussions of unifying mechanisms of matrix remodeling in valves and myocardium are presented. The mechanisms involved in the stimulation of cardiac fibrosis are not fully understood. In most cases the marginal attenuation of cardiac fibrosis as a result of a given therapy is a beneficial side-effect linked to other primary effects on other cells, especially cardiomyocytes. Very few drugs or agents are known to affect the function and dysfunction of cardiac fibroblasts and myofibroblasts alone. The book helps to translate the information gathered within to allow us to alter the course of fibrogenic events that are typical of cardiac fibrosis, and thereby reduce their burden on the patient and on society itself. 436 pp. Englisch. Seller Inventory # 9783319174365

More information about this seller | Contact this seller

Buy New
US$ 191.83
Convert currency

Add to Basket

Shipping: US$ 37.53
From Germany to U.S.A.
Destination, rates & speeds

6.

Dixon, Ian M.C.
Published by Springer (2017)
ISBN 10: 3319174363 ISBN 13: 9783319174365
New Paperback Quantity Available: 10
Print on Demand
Seller:
Ria Christie Collections
(Uxbridge, United Kingdom)

Book Description Springer, 2017. Paperback. Condition: New. PRINT ON DEMAND Book; New; Publication Year 2017; Fast Shipping from the UK. No. book. Seller Inventory # ria9783319174365_lsuk

More information about this seller | Contact this seller

Buy New
US$ 207.34
Convert currency

Add to Basket

Shipping: US$ 5.03
From United Kingdom to U.S.A.
Destination, rates & speeds

7.

Published by Springer (2015)
ISBN 10: 3319174363 ISBN 13: 9783319174365
New Hardcover Quantity Available: > 20
Print on Demand
Seller:
California Books
(MIAMI, FL, U.S.A.)

Book Description Springer, 2015. Condition: New. This book is printed on demand. Seller Inventory # I-9783319174365

More information about this seller | Contact this seller

Buy New
US$ 247.00
Convert currency

Add to Basket

Shipping: FREE
Within U.S.A.
Destination, rates & speeds

8.

Published by Springer International Publishing AG, Switzerland (2015)
ISBN 10: 3319174363 ISBN 13: 9783319174365
New Hardcover Quantity Available: 1
Seller:
The Book Depository EURO
(London, United Kingdom)

Book Description Springer International Publishing AG, Switzerland, 2015. Hardback. Condition: New. 2015 ed. Language: English. Brand new Book. The unique biology of cardiac fibroblasts and related cells, such as cardiac myofibroblasts and valvular interstitial cells, distinguish them from other fibroblastic cells, a concept that is only beginning to be widely appreciated. Further, the natural signals that stimulate and inhibit cardiac fibrosis within these cells are not well understood. This volume compiles articles that address the molecular mechanisms that control the synthesis and secretion of the cardiac ECM. The book showcases chapters that highlight discussion of role of Transforming Growth Factor ss (TGFss), an important fibrogenic cytokine and its downstream effectors SMAD in many cardiac diseases. Further, the contributions highlight information to discuss endogenous inhibitors of cardiac fibrosis, as well as advances in tissue engineering specific to matrix in the heart. Finally, discussions of unifying mechanisms of matrix remodeling in valves and myocardium are presented.The mechanisms involved in the stimulation of cardiac fibrosis are not fully understood. In most cases the marginal attenuation of cardiac fibrosis as a result of a given therapy is a beneficial side-effect linked to other primary effects on other cells, especially cardiomyocytes. Very few drugs or agents are known to affect the function and dysfunction of cardiac fibroblasts and myofibroblasts alone. The book helps to translate the information gathered within to allow us to alter the course of fibrogenic events that are typical of cardiac fibrosis, and thereby reduce their burden on the patient and on society itself. Seller Inventory # LIB9783319174365

More information about this seller | Contact this seller

Buy New
US$ 287.73
Convert currency

Add to Basket

Shipping: US$ 3.91
From United Kingdom to U.S.A.
Destination, rates & speeds